| Batch Notification Number |
BN-OL-2022-10-14-5357
|
| FDA Registered Product/Generic Name |
Co-Amoxiclav
|
| Brand Name |
Co-Amoxisaph-250
|
| Dosage Strength |
250 mg/ 62.5 mg per 5 mL
|
| Dosage Form |
Powder for Oral Suspension
|
| Registration Number |
DRP-8398
|
| Batch Number |
NXF-31
|
| Lot Number |
N/A
|
| Product Expiration Date |
Jan 2024
|
| Issuance Date |
19 October 2022
|